NCT00582855 - Effect of AQW051 in Patients With Memory Impairment | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

February 28, 2009

Conditions

Mild Alzheimer's DiseaseAmnestic Mild Cognitive Impairment

Interventions

DRUG

AQW051

DRUG

Placebo

Trial Locations (12)

Novartis Investigator Site, Halifax

Novartis Investigator Site, Montreal

Novartis Investigator Site, Toronto

Novartis Investigator Site, Bloemfontein

Novartis Investigator Site, George

Novartis Investigator Site, Port Elizabeth

Novartis Investigator Site, Blackpool

Novartis Investigator Site, Epping

Novartis Investigator Site, Glasgow

Novartis Investigator Site, Manchester

Novartis Investigator Site, Southampton

Novartis Investigator Site, Swindon